Clinical Governance & Training
Medicines Policy Development
Clear, practical medicines policies.
What does a medicines policy development service do?
Clear, practical medicines policies. BCS supports gp practices, primary care networks, gp federations across the UK from hubs in Halifax and London, covering repeat prescribing policy, high-risk drug policy, sops.
Reviewed October 2026 by the BCS clinical services team.
What is this service?
Medicines Policy Development from Bespoke Clinical Services: clear, practical medicines policies. Every arrangement is built around your organisation — truly bespoke, never off-the-shelf.
What can BCS support?
- Repeat prescribing policy
- High-risk drug policy
- SOPs
- Staff briefings
How can it be delivered?
- Audit projects
- Training programmes
- Ongoing QA
- As a defined project — no permanent contract needed
Who makes clinical decisions?
BCS clinicians work within their own competence and the scope you agree. Anything outside it is escalated to your GPs or clinical lead, under your organisation's clinical governance and procedures.
How clinical governance works →How does delivery start?
We agree the workload, scope, system access, escalation routes and reporting with you, complete clinician checks and induction, then start delivery. Progress is reviewed with you regularly.
Ways to commission →Why choose BCS?
BCS is a truly bespoke clinical services partner. We support 50+ PCNs and 300+ GP practices with 150+ clinical pharmacists, delivered from two hubs in Halifax and London. Every clinician is backed by our management layer, structured training, clinical supervision and quality assurance, and activity is reported clearly through the BCS Impact Dashboard.
How is it funded?
This is usually a defined, fixed-scope project funded from practice, PCN or commissioned budgets. Short-term or pay-as-you-go projects are not automatically ARRS-eligible.
Read our funding and ARRS guide →Common questions
What does a medicines policy development service do?
Clear, practical medicines policies. BCS supports gp practices, primary care networks, gp federations across the UK from hubs in Halifax and London, covering repeat prescribing policy, high-risk drug policy, sops.
Who is Medicines Policy Development for?
It's designed for gp practices, primary care networks, gp federations, icbs, care homes and care groups, nhs hospitals and community providers, independent healthcare providers. Every arrangement is tailored to your organisation.
Can medicines policy development be delivered remotely?
Yes. It can be delivered remotely, on-site, or a mix of both, from our hubs in Halifax and London.
Is medicines policy development ARRS funded?
This is usually a defined, fixed-scope project funded from practice, PCN or commissioned budgets. Short-term or pay-as-you-go projects are not automatically ARRS-eligible.
Who makes clinical decisions in medicines policy development?
BCS clinicians work within their own competence and the scope you agree. Anything outside it is escalated to your GPs or clinical lead, under your organisation's clinical governance and procedures.
How does medicines policy development start?
We agree the workload, scope, system access, escalation routes and reporting with you, complete clinician checks and induction, then start delivery. Progress is reviewed with you regularly.
Do I need a full-time contract?
No. You can commission a defined project with an agreed scope and timeline, without a permanent staffing agreement.
Request Medicines Policy Development
Tell us a little about your organisation and we'll come back within one working day with a bespoke proposal.